Sellas Life Sciences Group Inc (SLS)

Jun 18, 2025

SELLAS Life Sciences Holds Annual Stockholders Meeting - TipRanks

Jun 18, 2025

Jun 16, 2025

SELLAS Life Sciences: Tons Of Completed Studies (NASDAQ:SLS) - Seeking Alpha

Jun 16, 2025

Jun 13, 2025

Insider Buying: VAN NOSTRAND ROBERT L Acquires Additional Shares of SELLAS Life Sciences Group Inc (SLS) - GuruFocus

Jun 13, 2025

Jun 13, 2025

SELLAS Life Sciences Group Inc (SLS) Stock: A Year of Highs and Lows - investchronicle.com

Jun 13, 2025

Jun 13, 2025

Sellas Life Sciences director Van Nostrand buys $14,800 in stock By Investing.com - Investing.com South Africa

Jun 13, 2025

Jun 13, 2025

Sellas Life Sciences director Van Nostrand buys $14,800 in stock - Investing.com

Jun 13, 2025

Jun 05, 2025

SELLAS adds oncology experts to advisory board By Investing.com - Investing.com South Africa

Jun 05, 2025

Jun 05, 2025

SELLAS Life Sciences Expands Scientific Advisory Board with - GlobeNewswire

Jun 05, 2025

Jun 05, 2025

SELLAS Life Sciences Expands Scientific Advisory Board - citybiz

Jun 05, 2025

Jun 05, 2025

SELLAS adds oncology experts to advisory board - Investing.com

Jun 05, 2025

Jun 05, 2025

Leading Oncology Experts Join SELLAS Advisory Board as Critical AML Trial Results Near - Stock Titan

Jun 05, 2025

Jun 04, 2025

Northern Trust Corp Acquires 33,878 Shares of SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) - Defense World

Jun 04, 2025

Jun 03, 2025

Insider Buying: Jane Wasman Acquires 20,000 Shares of SELLAS Lif - GuruFocus

Jun 03, 2025

Jun 03, 2025

SELLAS reports potential colorectal cancer therapy progress By Investing.com - Investing.com South Africa

Jun 03, 2025

Jun 03, 2025

SELLAS reports potential colorectal cancer therapy progress - Investing.com India

Jun 03, 2025

Jun 02, 2025

Insider Buying: Jane Wasman Acquires 20,000 Shares of SELLAS Life Sciences Group Inc (SLS) - GuruFocus

Jun 02, 2025

Jun 02, 2025

SELLAS Life Sciences (SLS) Highlights Promising Results for SLS0 - GuruFocus

Jun 02, 2025

Jun 02, 2025

Sellas Life Sciences Group, Inc. Presents Preclinical Efficacy of Sls009 in Asxl1 Mutated Colorectal Cancer At 2025 Asco Annual Meeting - marketscreener.com

Jun 02, 2025

Jun 02, 2025

SELLAS Presents Preclinical Efficacy of SLS009 in ASXL1 Mutated Colorectal Cancer at 2025 ASCO Annual Meeting - GlobeNewswire

Jun 02, 2025

Jun 02, 2025

Breakthrough at ASCO: SELLAS Drug Shows Powerful Response in Targeted Colorectal Cancer Treatment - Stock Titan

Jun 02, 2025

May 26, 2025

National Bank Financial Comments on CVE:SLS FY2026 Earnings - Defense World

May 26, 2025

May 23, 2025

Insider Buying: Katherine Kalin Acquires 20,000 Shares of SELLAS Life Sciences Group Inc (SLS) - GuruFocus

May 23, 2025

May 23, 2025

US futures and global markets tumble after Trump threatens European Union with 50% tariffs and Apple with 25% tariff - The Globe and Mail

May 23, 2025

May 23, 2025

Director Makes Bold Move with Major Stock Purchase in SELLAS Life Sciences Group - TipRanks

May 23, 2025

May 20, 2025

Sellas Life Sciences Reports Improved Financial Position - TipRanks

May 20, 2025

May 20, 2025

SELLAS Life Sciences to Participate in Fireside Chat at the A.G.P. Virtual Healthcare Company Showcase - The Manila Times

May 20, 2025

May 20, 2025

SELLAS Life Sciences CEO to Reveal Latest Cancer Drug Development Strategy at Major Healthcare Conference - Stock Titan

May 20, 2025

May 16, 2025

Sellas doses first paediatric subject with AML in Phase II trial of SLS009 - Yahoo Finance

May 16, 2025

May 15, 2025

SELLAS advances pediatric AML treatment with Phase 2 trial By Investing.com - Investing.com South Africa

May 15, 2025

May 15, 2025

Sellas Life Sciences Doses 1st Pediatric Patient in Acute Myeloid Leukemia Study - marketscreener.com

May 15, 2025

May 15, 2025

SELLAS Life Sciences (SLS) Advances Phase 2 Trial for Pediatric AML | SLS Stock News - GuruFocus

May 15, 2025

May 15, 2025

SELLAS advances pediatric AML treatment with Phase 2 trial - Investing.com

May 15, 2025

May 15, 2025

SELLAS Life Sciences Announces First Pediatric AML Patient Dosed in the Ongoing Phase 2 Trial of SLS009 r/r AML - GlobeNewswire

May 15, 2025

May 15, 2025

Breakthrough: First Child with Resistant Leukemia Receives New Treatment in Major Clinical Trial - Stock Titan

May 15, 2025

May 14, 2025

SELLAS Life Sciences (SLS) Reports Improved Q1 Earnings Amid Fin - GuruFocus

May 14, 2025

May 14, 2025

SLS009 Shows Promising Results in Latest AML Trials | SLS Stock News - GuruFocus

May 14, 2025

May 14, 2025

SELLAS Life Sciences Reports First Quarter 2025 Financial Results and Provides Corporate Update - The Manila Times

May 14, 2025

May 13, 2025

SELLAS Life Sciences Group Reports Positive Overall Survival Data for SLS009 in r/r AML and Updates on Financial Position and Pipeline Developments - Nasdaq

May 13, 2025

May 12, 2025

Blood Cancer Treatment Market Sees Accelerated Growth Across the 7MM Amid Rising Incidence and Breakthroughs | DelveInsight - GlobeNewswire Inc.

May 12, 2025

May 11, 2025

SELLAS Life Sciences Group (SLS) Expected to Announce Quarterly Earnings on Tuesday - Defense World

May 11, 2025

May 07, 2025

Upward Trajectory: SELLAS Life Sciences Group Inc (SLS) Posts a Gaine, Closing at 1.72 - DWinneX

May 07, 2025

May 02, 2025

Financial Metrics Exploration: Understanding SELLAS Life Sciences Group Inc (SLS) Through Ratios - DWinneX

May 02, 2025

May 02, 2025

Geode Capital Management LLC Purchases 128,355 Shares of SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) - Defense World

May 02, 2025

Apr 30, 2025

Wall Street analysts’ outlook for SELLAS Life Sciences Group Inc (SLS) - Sete News

Apr 30, 2025

Apr 29, 2025

SELLAS Life Sciences Group Inc’s latest rating changes from various analysts - knoxdaily.com

Apr 29, 2025

Apr 29, 2025

SELLAS Life Sciences Group Inc (SLS) Stock: The Story of a 52-Week Stock Range - investchronicle.com

Apr 29, 2025

Apr 29, 2025

Understanding the Risks of Investing in La Rosa Holdings Corp (LRHC) - knoxdaily.com

Apr 29, 2025

Apr 28, 2025

SELLAS reports promising AML treatment in preclinical study - Investing.com

Apr 28, 2025